Measurement of intracellular triglyceride stores by 1H spectroscopy:: validation in vivo

被引:599
作者
Szczepaniak, LS
Babcock, EE
Schick, F
Dobbins, RL
Garg, A
Burns, DK
McGarry, JD
Stein, DT
机构
[1] Univ Texas, SW Med Ctr, Ctr Diabet Res, Dallas, TX 75235 USA
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75235 USA
[3] Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA
[4] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75235 USA
[5] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA
[6] Univ Tubingen, Dept Radiol, D-72706 Tubingen, Germany
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1999年 / 276卷 / 05期
关键词
fatty acid analysis; quantification; dog; rabbit; human; congenital generalized lipodystrophy; proton; skeletal muscle; liver;
D O I
10.1152/ajpendo.1999.276.5.E977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We validate the use of H-1 magnetic resonance spectroscopy (MRS) to quantitatively differentiate between adipocyte and intracellular triglyceride (TG) stores by monitoring the TG methylene proton signals at 1.6 and 1.4 ppm, respectively. In two animal models of intracellular TG accumulation, intrahepatic and intramyocellular TG accumulation was confirmed histologically. Consistent with the histological changes, the methylene signal intensity at 1.4 ppm increased in both liver and muscle, whereas the signal at 1.6 ppm was unchanged. In response to induced fat accumulation, the TG concentration in liver derived from H-1 MRS increased from 0 to 44.9 +/- 13.2 mu mol/g, and this was matched by increases measured biochemically(2.1 +/- 1.1 to 46.1 +/- 10.9 mu mol/g). Supportive evidence that the methylene signal at 1.6 ppm in muscle is derived from investing interfascial adipose tissue was the finding that, in four subjects with generalized lipodystrophy, a disease characterized by absence of interfacial fat, no signal was detected at 1.6 ppm; however, a strong signal was seen at 1.4 ppm. An identical methylene chemical shift at 1.4 ppm was obtained in human subjects with fatty liver where the fat is located exclusively within hepatocytes. In experimental animals, there was a close correlation between hepatic TG content measured in vivo by H-1 MRS and chemically by liver biopsy [R = 0.934; P < .0001; slope 0.98, confidence interval(CI) 0.70-1.17; gamma-intercept 0.26, CI -0.28 to 0.70]. When applied to human calf muscle, the coefficient of variation of the technique in measuring intramyocellular TG content was 11.8% in nonobese subjects and 7.9% in obese subjects and of extramyocellular (adipocyte) fat was 22.6 and 52.5%, respectively. This study demonstrates for the first time that noninvasive in vivo H-1 MRS measurement of intracellular TG, including that within myocytes, is feasible at 1.5-T field strengths and is comparable in accuracy to biochemical measurement. In addition, in mixed tissue such as muscle, the method is clearly advantageous in differentiating between TG from contaminating adipose tissue compared with intramyocellular lipids.
引用
收藏
页码:E977 / E989
页数:13
相关论文
共 71 条
  • [51] Manery JF, 1939, J BIOL CHEM, V127, P657
  • [52] MEIER JM, 1972, J LIPID RES, V13, P228
  • [53] Multiecho approaches to spectroscopic imaging of the brain
    Mulkern, RV
    Chao, H
    Bowers, JL
    Holtzman, D
    [J]. IMAGING BRAIN STRUCTURE AND FUNCTION: EMERGING TECHNOLOGIES IN THE NEUROSCIENCES, 1997, 820 : 97 - 122
  • [54] INVIVO H-1 SPECTROSCOPIC STUDIES OF HUMAN GASTROCNEMIUS-MUSCLE AT 1.5 T
    NARAYANA, PA
    HAZLE, JD
    JACKSON, EF
    FOTEDAR, LK
    KULKARNI, MV
    [J]. MAGNETIC RESONANCE IMAGING, 1988, 6 (05) : 481 - 485
  • [55] INVIVO LOCALIZED PROTON SPECTROSCOPIC STUDIES OF HUMAN GASTROCNEMIUS-MUSCLE
    NARAYANA, PA
    JACKSON, EF
    HAZLE, JD
    FOTEDAR, LK
    KULKARNI, MV
    FLAMIG, DP
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1988, 8 (02) : 151 - 159
  • [56] REGULATION OF CHOLESTEROL METABOLISM IN DOG .2. EFFECTS OF COMPLETE BILE DIVERSION AND OF CHOLESTEROL FEEDING ON POOL SIZES OF TISSUE CHOLESTEROL MEASURED AT AUTOPSY
    PERTSEMLIDIS, D
    KIRCHMAN, EH
    AHRENS, EH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (09) : 2368 - 2378
  • [57] SARNAT HB, 1983, MUSCLE PATHOLOGY HIS, P137
  • [58] SCHICK F, 1993, MAGN RESON MED, V29, P158, DOI [10.1002/mrm.1910290203, 10.1007/BF01769418]
  • [59] SNYDER WS, 1984, REPORT TASK GROUP RE, P110
  • [60] STEIN DT, 1995, INT J OBESITY, V19, P804